Endocyte Inc $13.24
|Trade Time:||Mar 07 08:10 PM Eastern Daylight Time|
|Change:||0.07 (0.53 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get ECYT Trend Analysis - it has outperformed the S&P 500 by 18%
|No ETF alternatives available.|
|Date||Name||Title||Volume||Trade Price||Holding Change|
|2/14/2014||Low Philip S||Chief Science Officer||-6,000||$15.00||-2.90%|
|2/11/2014||Low Philip S||Chief Science Officer||1,000||$1.91||0.49%|
|1/14/2014||Low Philip S||Chief Science Officer||1,000||$1.91||0.51%|
|12/17/2013||Low Philip S||Chief Science Officer||1,000||$1.91||0.51%|
|12/04/2013||Ellis P Ron||President and CEO||3,000||$1.91||11.47%|
ECYT Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!